BioLife Solutions (BLFS) had the highest return in 1991 by a US stock in the Nasdaq Composite (IXIC), returning 766%.
| ASSET | YEAR | % RETURN |
|---|---|---|
BioLife Solutions (BLFS) | 1991 | 765.98% |
Biomerica (BMRA) | 1991 | 652.94% |
Jack Henry & Associates (JKHY) | 1991 | 536.01% |
Abeona Therapeutics (ABEO) | 1991 | 433.51% |
Vicor (VICR) | 1991 | 398.56% |
Heron Therapeuti (HRTX) | 1991 | 394.12% |
Mesa Laboratories (MLAB) | 1991 | 383.35% |
Veru (VERU) | 1991 | 325.4% |
STAAR Surgical (STAA) | 1991 | 306.95% |
Bio-Techne (TECH) | 1991 | 304.04% |
Electronic Arts (EA) | 1991 | 302.6% |
Educational Development (EDUC) | 1991 | 299.7% |
Plexus (PLXS) | 1991 | 289.75% |
Merit Medical Systems (MMSI) | 1991 | 274.31% |
Bel Fuse A (BELFA) | 1991 | 268.42% |
Celldex Therapeutics (CLDX) | 1991 | 266.67% |
Amgen (AMGN) | 1991 | 256.48% |
PTC (PTC) | 1991 | 254.41% |
Advanced Micro Devices (AMD) | 1991 | 250% |
GT Biopharma (GTBP) | 1991 | 240% |
RadNet (RDNT) | 1991 | 231.58% |
Genesis Healthcare (GEN) | 1991 | 229.65% |
CECO Environmental (CECO) | 1991 | 224.98% |
Axogen (AXGN) | 1991 | 217.86% |
Research Frontiers (REFR) | 1991 | 200.01% |
